EUCTR2010-020098-18-FR进行中(未招募)不适用
CrYSTobs A cohort of patients with cystinosis : compliance to cysteamine and neurological complicationsAn auxiliary study to Raptor RP103 03 and RP103 04 - CrYSTobs
HOSPICES CIVILS DE LYO0 个研究点开始时间: 2010年7月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with nephropathic cystinosis
- •- Male and female subjects with confirmed diagnosis of nephropathic cystinosis (defined by clinical signs and WBC cystine level).
- •- Age > 6 years.
- •- Subjects receiving any oral cysteamine treatment: Cystagon? or RP103.
- •- Subjects must be able to swallow their typically administered cysteamine treatment.
- •- Sexually active female subjects of childbearing potential must agree to utilize the same acceptable form of contraception from day 1 through completion of the study.
- •- Subjects or their parent or legal guardian must provide written informed consent prior to participation in the study.
- •- Subjects covered by or having the right to social security.
- •- Age and sex matched to study population :
- •Age range : patients aged 6 to 11 years , patients aged 12 to 17 years, adult patients: 18 or above.
- •Sex : male or female
- •- Subjects or their parent or legal guardian must provide written informed consent prior to participation in the study.
- •- Subjects covered by or having the right to social security.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with nephropathic cystinosis
- •- Subjects receiving any form of cysteamine medication through a gastric tube.
- •- Subjects with known hypersensitivity to cysteamine and penicillamine.
- •- Females who are nursing, planning a pregnancy, known or suspected to be pregnant, or with a positive urinary pregnancy test.
- •- Subjects who, in the opinion of the Investigator, are not able or willing to comply with the protocol.
- •Contra-indication to MRI assessment
- •Controls for metabonomic assessment
- •- Any uropathology or nephropathology.
研究者
相似试验
招募中
不适用
Development of Health-related Quality of Life Instrument for Patients With CystinosisCystinosisNCT05959668Cystinose Stiftung300
尚未招募
3 期
Effect of Albendazole and steroids vs steroids alone on whole body MRI in disseminated cysticercosis patients.CTRI/2022/12/048558KING GEORGE MEDICAL UNIVERSITY,UTTAR PRADESH LUCKNOW
已完成
不适用
Identification of the association of cyst-infected bacteria and enterobacterial floraPolycystic kidney disease Polycystic liver diseaseJPRN-UMIN000025630Toranomon Hospital40
已完成
Unknown
Pre- and post-surgical medical treatment of human cystic echinococcosisCystic echinococcosisInfections and InfestationsISRCTN78387420niversity of the Republic36
已完成
不适用
Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With CystinosisCystinosisNCT00010426FDA Office of Orphan Products Development30
